Yongquan J. Wang
23 Postal Street
Harbin, 150000, China
Harbin, 150000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences.
Journal: Molecular biomedicine
Published: April 29, 2026
Case report: Suspected adrenal crisis after non-functional adrenal tumor resection: a case of temporal association with perioperative dexamethasone.
Journal: Frontiers in endocrinology
Published: March 12, 2026
A cfDNA fragmentomics classifier for noninvasive differentiation of benign and malignant renal masses.
Journal: Molecular biomedicine
Published: January 12, 2026
Sintilimab Plus Axitinib for Advanced Fumarate Hydratase-Deficient Renal Cell Carcinoma: A Phase 2 Nonrandomized Clinical Trial.
Journal: JAMA oncology
Published: August 14, 2025
Case report: Von Hippel-Lindau syndrome with multisystem involvement: a therapeutic dilemma.
Journal: Frontiers in oncology
Published: May 23, 2025
First-line benmelstobart plus anlotinib versus sunitinib in advanced renal cell carcinoma (ETER100): a multicentre, randomised, open-label, phase 3 trial.
Journal: The Lancet. Oncology
Published: March 18, 2025
CircABCA1 promotes ccRCC by reprogramming cholesterol metabolism and facilitating M2 macrophage polarization through IGF2BP3-mediated stabilization of SCARB1 mRNA.
Journal: Molecular cancer
Published: March 10, 2025
Co-Existing Ectopic Cortisol-Producing Adenoma and Retroperitoneal Schwannoma, a Rare Case Report.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: July 17, 2024
Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets.
Journal: Nature communications
Published: March 06, 2024
A novel peptide PDHK1-241aa encoded by circPDHK1 promotes ccRCC progression via interacting with PPP1CA to inhibit AKT dephosphorylation and activate the AKT-mTOR signaling pathway.
Journal: Molecular cancer
Published: October 03, 2023
Memory/Active T-Cell Activation Is Associated with Immunotherapeutic Response in Fumarate Hydratase-Deficient Renal Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 12, 2023
Last Updated: 09/26/2026